Technical Analysis for TNDM - Tandem Diabetes Care, Inc.

Grade Last Price % Change Price Change
grade A 102.76 -1.30% -1.35
TNDM closed down 1.3 percent on Friday, July 10, 2020, on 36 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: Jul 30
*** please verify all earnings dates ***

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical TNDM trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Spinning Top Other 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
New 52 Week Closing High Bullish -1.30%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.30%
Upper Bollinger Band Walk Strength -1.30%
Wide Bands Range Expansion -1.30%
Overbought Stochastic Strength -1.30%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Tandem Diabetes Care, Inc., a medical device company, focuses on the design, development, and commercialization of various products for people with insulin-dependent diabetes. The company's products include t:slim Insulin Delivery System that comprises t:slim pump, its disposable cartridge, and an infusion set; and t:connect Diabetes Management Application, a PC and Mac-compatible, cloud-based data management application that provides users, their caregivers, and their healthcare providers a fast, easy, and visual way to display therapy management data from the pump and supported blood glucose meters. It sells its products in the United States. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was founded in 2006 and is headquartered in San Diego, California.
Medicine Diabetes Healthcare Providers Endocrine System Diabetes Mellitus Insulin Endocrinology Diabetes Care Diabetes Management Diabetes Mellitus Type 1 Insulin Delivery Insulin Dependent Diabetes

Is TNDM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 106.18
52 Week Low 43.69
Average Volume 1,370,643
200-Day Moving Average 71.36
50-Day Moving Average 87.19
20-Day Moving Average 92.29
10-Day Moving Average 98.49
Average True Range 4.77
ADX 28.14
+DI 29.27
-DI 11.39
Chandelier Exit (Long, 3 ATRs ) 91.86
Chandelier Exit (Short, 3 ATRs ) 91.55
Upper Bollinger Band 108.15
Lower Bollinger Band 76.43
Percent B (%b) 0.83
BandWidth 34.36
MACD Line 5.45
MACD Signal Line 4.20
MACD Histogram 1.253
Fundamentals Value
Market Cap 516.22 Million
Num Shares 5.02 Million
EPS -25.15
Price-to-Earnings (P/E) Ratio -4.09
Price-to-Sales 0.17
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 107.58
Resistance 3 (R3) 107.74 106.31 106.77
Resistance 2 (R2) 106.31 105.08 106.22 106.50
Resistance 1 (R1) 104.53 104.32 103.82 104.37 106.24
Pivot Point 103.10 103.10 102.74 103.01 103.10
Support 1 (S1) 101.32 101.87 100.61 101.16 99.28
Support 2 (S2) 99.89 101.11 99.80 99.02
Support 3 (S3) 98.11 99.89 98.75
Support 4 (S4) 97.95